Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Full text

Author Correction: TGF-βinduces miR-100 and
miR-125b but blocks let-7a through LIN28B
controlling PDAC progression
Silvia Ottaviani 1, Justin Stebbing1, Adam E. Frampton 2,3, Sladjana Zagorac1, Jonathan Krell3,
Alexander de Giorgio1, Sara M. Trabulo4,5, Van T.M. Nguyen1, Luca Magnani 1, Hugang Feng6,
Elisa Giovannetti7,8, Niccola Funel8, Thomas M. Gress9, Long R. Jiao2, Ylenia Lombardo1, Nicholas R. Lemoine10,
Christopher Heeschen4,5 & Leandro Castellano 1,11
Correction to: Nature Communications https://doi.org/10.1038/s41467-018-03962-x, published online 10 May 2018
The original version of this Article omitted a declaration from the competing interests statement, which should have included the
following: ‘One of the authors, Y.L., is an editor on the staff of Nature Communications, but was not in any way involved in the journal
review process. The other authors declare no competing interests’. This has now been corrected in both the PDF and HTML versions of
the Article.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit
line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2019
https://doi.org/10.1038/s41467-019-11752-2 OPEN
1Department of Surgery and Cancer, Division of Cancer, Imperial College London, Imperial Centre for Translational and Experimental Medicine (ICTEM),
London W12 0NN, UK. 2Department of Surgery and Cancer, HPB Surgical Unit, Imperial College, Hammersmith Hospital Campus, London W12 0HS, UK.
3Department of Surgery and Cancer, Division of Cancer, Imperial College London, Institute of Reproductive and Developmental Biology (IRDB), London W12
0NN, UK. 4Stem Cells & Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid 28028, Spain. 5Stem Cells in Cancer & Ageing, Barts
Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK. 6Epigenetics and Genome Stability Team, The Institute of Cancer Research, 237
Fulham Road, London SW3 6JB, UK. 7Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam 1081 HV, The
Netherlands. 8Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa 56126, Italy. 9Clinic for Gastroenterology, Endocrinology, Metabolism
and Infectiology, Philipps-University Marburg, Marburg 35037, Germany. 10 Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of
London, London EC1M 6BQ, UK. 11University of Sussex, School of life Sciences, John Maynard Smith Building, Falmer, Brighton BN1 9QG, UK. These authors
contributed equally: Silvia Ottaviani, Justin Stebbing. Correspondence and requests for materials should be addressed to L.C. (email: l.castellano@sussex.ac.uk)
NATURE COMMUNICATIONS | (2019) 10:3738 | https://doi.org/10.1038/s41467-019-11752-2 | www.nature.com/naturecommunications 1
1234567890():,;
Content courtesy of Springer Nature, terms of use apply. Rights reserved

1.
2.
3.
4.
5.
6.
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
accessing, sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
not:
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
control;
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
onlineservice@springernature.com